Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Frontiers in Oncology|January 31, 2014
BRCA and Early Events in the Development of Serous Ovarian CancerSophia H L George, Patricia ShawCancer Discovery|September 6, 2023
Challenges and Opportunities in Building a Global Representative Single-Cell and Spatial Atlas in CancerJasmine T Plummer, Sophia H L GeorgeFrontiers in Oncology|May 21, 2016
Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for PreventionSophia H L George, Ruslan Garcia, Brian M SlomovitzClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2012
Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation statusSophia H L George, Anca Milea, Patricia A ShawBreast Cancer Research : BCR|August 5, 2022
Racial disparities in breast cancer preclinical and clinical modelsShannique Clarke, Sheray N Chin, Leah Dodds, et al.Gynecologic Oncology Reports|August 23, 2016
Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patientRyan Kahn, Arlene Garcia-Soto, Rachel Silva-Smith, et al.American Journal of Human Genetics|November 23, 2023
Increasing diversity of functional genetics studies to advance biological discovery and human healthSophia H L George, Alejandra Medina-Rivera, Youssef Idaghdour, et al.Frontiers in Oncology|October 3, 2022
Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy - non-mitotic mechanisms of paclitaxelElizabeth R Smith, Marilyn Huang, Matthew P Schlumbrecht, et al.Breast Cancer Research and Treatment|August 16, 2019
Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrantsPriscila Barreto-Coelho, Danielle Cerbon, Matthew Schlumbrecht, et al.Stem Cells (Dayton, Ohio)|September 6, 2008
Soluble Flt-1 regulates Flk-1 activation to control hematopoietic and endothelial development in an oxygen-responsive mannerKelly A Purpura, Sophia H L George, Stephen M Dang, et al.Pageof 4